Bertis unveils positive research results for new biomarker to detect ovarian cancer
South Korea-based Bertis has unveiled positive results from its research on protein biomarkers for early diagnosis of high-grade serous ovarian cancer (HGSOC). The proteomics-based molecular diagnostics company said